Reporting on Adverse Clinical Events, 2018

DOI: 10.1177/0069477018792084

Keywords: Amantadine (192),Anticoagulants,Oral (194),Antidepressants (199),Antipsychotics (191),Benzodiazepines (196),Calcium Channel Blockers (202),Daptomycin (189),Darunavir/Cobicistat (203),Estrogens,Conjugated (201),Fluoroquinolones (195),Hypnotics (196),Kratom (197),Nivolumab (200),Pregabalin (193),Ranitidine (190),Tacrolimus (201),Ziconotide (198)

Full-Text